iiinova — where your digital self keeps evolving

Graph @graphtx.bsky.social · 24/09/2026

How accurately do ex vivo models represent real disease states? At #TargetV26, @izepb.bsky.social shared how we’re mapping ex vivo conditions against reference disease atlases using single-cell imaging & transcriptomics to measure their true clinical delta. Full poster here 👉 lnkd.in/d5FVKrup

130

Graph @graphtx.bsky.social · 14/09/2026

🇬🇧 Hinxton, see you 21 - 23 September at the conference Target Validation - In the Era of Genomics, Big Data, and AI! @izepb.bsky.social, Principal Scientist at Graph, will present how we quantify ex vivo model realism and compound reversal for target discovery in inflammatory disease.

130

Graph @graphtx.bsky.social · 03/07/2026

We’re hiring! 📢 We're looking for a: ➕ Translational Immunologist Validate the key causal drivers behind immune-mediated disease using more realistic biological and computational models. Read more and apply here: www.linkedin.com/jobs/view/44...

linkedin.com

GraphTx hiring Translational Immunologist in Klosterneuburg, Lower Austria, Austria | LinkedIn

Posted 1:19:11 PM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.

110

Graph @graphtx.bsky.social · 23/06/2026

We're hiring! 📢 ➕ Translational Systems Biologist ➕ Research Data Engineer You’ll join an international team that values participation & collaboration, where you’ll be able to actively shape decisions, culture, & strategy. Apply here ➡️ graph-therapeutics.jobs.personio.com?language=en

020

Graph @graphtx.bsky.social · 22/06/2026

📢 Exciting news! Paris-based VC firm daphni has joined our investor syndicate, leading an additional $5M investment, with continued participation from SquareOne, Merantix Capital, & NAVEC Investment Management. This brings our total funding, including non-dilutive grant support, to over $10M.

140

Graph @graphtx.bsky.social · 30/04/2026

Ahoj Prague! 🇨🇿 Desy Vallorani, Research Assistant at Graph, will be attending Autoimmunity 2026 from 14 - 17 May! As we continue to decode complex immune dysfunction at scale, we’re looking forward to discussing the latest breakthroughs in inflammatory and immune-mediated diseases. ➕✖️

010

Graph @graphtx.bsky.social · 27/04/2026

We’re hiring! 📢 We are scaling up our wet lab capabilities and are looking for a Molecular Immunologist to join our team. Consider applying if you are someone who wants to interrogate and validate immune-mediated disease drivers. 🧬🔍🥼 Read the full job description ➡️ lnkd.in/dX6jUgpN

lnkd.in

GraphTx hiring Molecular Immunologist in Klosterneuburg, Lower Austria, Austria | LinkedIn

Posted 1:55:21 PM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.

010

Graph @graphtx.bsky.social · 23/04/2026

Meet the team behind Graph and say hello to @benhaladik.bsky.social, Scientist! 🧗🛹 With Ben’s help, we’re combining live patient cell models with advanced machine learning to decode complex immune dysfunction, driving our lab-in-the-loop platform. ➕✖️

020

Graph @graphtx.bsky.social · 20/04/2026

We're hiring! 📢 Our team is looking for a Full Stack Biologist driving research at the interface of computational & lab biology. Consider applying if you want to better understand the causal mechanisms of disease using multi-modal, realistic primary cell models. ⚙️ 🧬 💡 Apply here ➡️ lnkd.in/dBuA73nG

lnkd.in

GraphTx hiring Full Stack Biologist in Klosterneuburg, Lower Austria, Austria | LinkedIn

Posted 6:37:27 AM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.

020

Graph @graphtx.bsky.social · 17/04/2026

Today's rheumatoid arthritis (RA) therapies only slow disease. The next generation needs to cure it, and that first requires a comprehensive map of immune dysfunction. At IMMUNOLOGY2026, Graph's co-founder & VP Immunology Christophe Boudesco presented the latest results from our platform FIM. 🏗️ ⚙️

110

Graph @graphtx.bsky.social · 02/04/2026

Attending IMMUNOLOGY2026? Stop by the Parse x Graph happy hour to talk science & to celebrate our joint partnership to create one of the largest & most comprehensive immune cell perturbation atlases. 🧬🔍 📆 16 April 2026, 19:00 📍 Trillium Brewing Fort Point 🎟️ RSVP: lnkd.in/d7sbWbEA

130

Graph @graphtx.bsky.social · 24/03/2026

Hey Boston, we’ll be attending #IMMUNOLOGY2026 from 16 - 19 April! Connect with us over our work in immune dysfunction mapping for next generation drug discovery in rheumatoid arthritis.

110

Graph @graphtx.bsky.social · 11/03/2026

Join us for a guest talk with @psl-schaefer.bsky.social (@saezlab.bsky.social, Uni Heidelberg)! 💬 Machine Learning for Cellular Perturbations at Scale: Current Capabilities, Limits, and Open Questions 📆 17 March 2026, 13:30 - 14:30 📍 LBI NetMed, Julius-Tandler-Platz 3, Top 5.1, 1090 Vienna

120

Graph @graphtx.bsky.social · 24/02/2026

Meet the team behind Graph and say hello to Rin Okumura, Senior Scientist! 🧗⛷️ With Rin on the team, we’re scaling lab-in-the-loop discovery by translating complex biology to high-throughput automated workflows. ➕✖️

020

Graph @graphtx.bsky.social · 30/01/2026

New look, same mission. 🧑‍🚀 🚀 We’re excited to debut our updated website that reflects who we are and the work we are doing at Graph: unafraid and boldly confronting the dynamic behavior of immune biology head on. Check it out 🌐 www.graphtx.com

130

Graph @graphtx.bsky.social · 28/01/2026

In our latest talk & poster presentation at the Keystone Autoimmunity & Autoinflammation symposium, Graph’s co-founder & CSO Bojan Vilagos presented our generalizable & scalable approach for discovering shared mechanisms across disease contexts. 🧬 ⚙️ Full poster here 👉 graphtx.com/inflammasome...

120

Graph @graphtx.bsky.social · 20/01/2026

Parse Biosciences and Graph are partnering to create the world's most comprehensive immune cell perturbation atlas aimed at revealing immune system dysfunction for curative drug discovery. 🧬 🗺️ ➡️ Read more: www.parsebiosciences.com/news/parse-b...

140

Graph @graphtx.bsky.social · 15/01/2026

Fantastic panel at the Evotec Breakfast Reception in SF! Graph co-founder @gregvladimer.bsky.social shared insights alongside leaders from @isomorphiclabs.bsky.social & @medra-ai.bsky.social about how AI helps to unlock disease mechanisms & supports the development of future bio discoveries. 🚀

030

Graph @graphtx.bsky.social · 13/01/2026

🏔️ Hey Colorado, we’ll be up in the Rockies from 19 - 22 January 2026 for the Autoimmunity & Autoinflammation symposium! We’re looking forward to showcasing our approach of using advanced imaging & data modeling to find clinically-relevant targets & pathways for immune diseases in our latest poster.

110

Graph @graphtx.bsky.social · 17/12/2025

🌊 ⛵ Hey San Francisco, on 13 January 2026 adjacent to the 44th Annual JPM Healthcare Conference, Graph’s co-founder and CEO Greg Vladimer will be speaking on Evotec's panel “Precision at Scale: AI’s impact on Drug Discovery." Let us know if you are in San Francisco and let’s talk techbio!

030

Graph @graphtx.bsky.social · 10/12/2025

Just last week, we had a group retreat (aka Graph Con) to a mountain hut in the Alps 🇦🇹. We spent some time honing our cooking skills, enjoying the wintry landscape, and forging our 2026 strategy around immune dysfunction mapping. We’re already energized for 2026, and we’re just getting started. 💫

021

Graph @graphtx.bsky.social · 26/11/2025

Thank you to everyone who attended our AI x Bio meetup last week in Berlin! We had a great time catching up with old friends and making new connections. 🪩 🕺 👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!

020

Graph @graphtx.bsky.social · 24/11/2025

What does it takes to build real prediction power for precision immunology? Hint: it's about mapping immune dysfunction and scaling what's relevant. ➡️ Have a look at what we're building at Graph: graphtx.substack.com/p/building-t...

graphtx.substack.com

Building the Data Foundation to Scale Precision Immunology

Towards context-conditioned foundation models of immune dysfunction

030

Graph @graphtx.bsky.social · 21/11/2025

Immune-mediated diseases are highly complex and heterogeneous, which makes the discovery of precision medicines difficult. In Graph’s most recent poster at #CytoData2025, our research team showcased our systematic approach to address this challenge. 🎯

140

Graph @graphtx.bsky.social · 10/11/2025

Hey Berlin, we’ll be in town from 20 - 21 November for CytoData 2025! If you want to know more about how we are decoding the functional and molecular niche of immune-mediated diseases for iterative target discovery, come by our poster session to learn more!

120

Graph @graphtx.bsky.social · 28/10/2025

Meet the team behind Graph and say hello to @izepb.bsky.social, Principal Scientist! 🧬⛰️ Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️

020

Graph @graphtx.bsky.social · 14/10/2025

You’re invited to join us for an evening to connect with others building at the intersection of biology, technology, and AI: 📅 19 November 2025, 18:30 📍 Merantix AI Campus, Berlin 👉 Sign up: lu.ma/u4i3i1i3 We’re excited to see you there and to talk about the future of techbio with you! 💡⚙️

lu.ma

Berlin AI x Bio Meetup · Luma

Graph Therapeutics, Merantix Capital, and TechBio Transformers (TBT) are bringing together techbio enthusiasts and experts in Berlin for a meetup, timed…

042

Graph @graphtx.bsky.social · 07/10/2025

✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!

120

Graph @graphtx.bsky.social · 02/10/2025

Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.

120

Graph @graphtx.bsky.social · 30/09/2025

Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬 With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️

030

Graph @graphtx.bsky.social · 22/09/2025

Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬

020

Graph @graphtx.bsky.social · 10/09/2025

How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️

130

Graph @graphtx.bsky.social · 08/09/2025

Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕

120

Graph @graphtx.bsky.social · 27/08/2025

Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼 Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️

021

Graph @graphtx.bsky.social · 04/08/2025

Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬

040

Graph @graphtx.bsky.social · 29/07/2025

With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿 Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...

030

Graph @graphtx.bsky.social · 25/07/2025

After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data. ➡️ Check it out: graphtx.substack.com/p/precision-...

graphtx.substack.com

Precision immunology requires precision data

After a decade iterating on AI drug discovery platforms from Allcyte/Exscientia to Graph, precision medicine demands active investment in data, biological context, and repeated experimental validation

020

Graph @graphtx.bsky.social · 18/07/2025

Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜 Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️

030

Graph @graphtx.bsky.social · 30/06/2025

Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️

072

Graph @graphtx.bsky.social · 14/06/2025

We're hiring! 📢 Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍 Want to know more? Reach out to us and apply via the link below! ⬇️ www.linkedin.com/jobs/view/42...

linkedin.com

Graph Therapeutics hiring Quantitative Systems Biologist (m/f/d) in Klosterneuburg, Lower Austria, Austria | LinkedIn

Posted 4:35:54 PM. Be at the forefront of AI-driven precision immunology for drug discoverytl;dr: Graph is an…See this and similar jobs on LinkedIn.

063

Graph @graphtx.bsky.social · 26/05/2025

Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬 We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️

Poster with a portrait photo of Daniel Thomas, MLOps & data engineer for Graph Therapeutics.

041

Graph @graphtx.bsky.social · 21/05/2025

💡How are we using disease perturbational modeling & AI to transform the treatment of immunological diseases? In the AWS Health podcast, Graph's co-founder & CEO @gregvladimer.bsky.social talks science, tech, & where the future is headed in target discovery. 🎧 Check out the podcast! ➡️ bit.ly/43b5LAw

bit.ly

#123, Decoding Immune Cell Behavior to Transform Treatment Discovery with Gregory Vladimer from Graph Therapeutics

Graph Therapeutics combines AI-driven perturbation modeling with multi-omics data to develop targeted therapies for patients with complex immune-mediated diseases who currently lack effective treatmen...

021

Reposted by Graph

Katherine Driscoll @kdris.bsky.social · 25/04/2025

Excited to be joining the panel discussion later today! ✨ Mark your calendars! 📅 The @WiMLWorkshop Social returns to @iclrconf! 🗓️ Friday, April 25th, 2025 ⏰ 12:30 PM - 2:00 PM 📍 Hall 1 Apex, Singapore Expo iclr.cc/virtual/2025... lu.ma/ftdnjnf9 #ICLR2025

141

Graph @graphtx.bsky.social · 24/04/2025

Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬

051

Graph @graphtx.bsky.social · 22/04/2025

Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬

Graph at ICLR 2025 in Singapore from 24 - 28 April. Meet us there!

A portrait of Katherine Driscoll, Head of AI at Graph, standing in front of a blackboard with mathematical formulas.

052

Reposted by Graph

Ize Buphamalai @izepb.bsky.social · 04/04/2025

Just came back from the IRB conference in Barcelona on BioxAI. Still amazed by the speed at which (Gen)AI is already transforming comp bio research. Had fun catching up with familiar faces and made new connections. Huge thanks to the organisers for putting up cool program with top-notch line ups!

061

Graph @graphtx.bsky.social · 26/03/2025

📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥 ➡️ Read more: immune.engineering/news/dr-bere...

Portrait of Professor Berend Snijder with a blue button-down shirt against a blurred concrete background.

050

Graph @graphtx.bsky.social · 24/03/2025

¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋

A poster for Graph at the AI in Drug Discovery and Biomedicine conference in Barcelona, Spain from 31 March to 2 April, 2025.

A photo of Ize Buphamalai, Principal Scientist at Graph.

031

Graph @graphtx.bsky.social · 18/03/2025

We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹 @gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏

Graph CEO Gregory Vladimer stands at a podium in the center of the BIO-Europe Spring presentation stage with the introductory slide to Graph in the background.

142

Graph @graphtx.bsky.social · 03/03/2025

Graph has been awarded an Austrian Life Sciences grant worth EUR 1.1M from the FFG (Austrian Research Promotion Agency)! This funding helps us continue to develop our lab-in-the-loop AI-driven approach to discover better therapeutics for immune-mediated diseases. 🔬🚀

031